Search results
Pathology Asia believes it takes a doctor to know a doctor. That's why we are medically managed with doctors at the centre of decision making. Our mission is to make high quality diagnostic services accessible and affordable throughout Southeast Asia’s c.680 million population.
With leading medical diagnostic laboratories in Singapore, Malaysia, Vietnam, the Philippines, Indonesia and Australia; as well as a digital platform for healthcare providers, Pathology Asia aspires to be the foremost trusted diagnostics services provider in Southeast Asia and Australasia.
Pathology Asia is headquartered in Singapore with a presence in Southeast Asia and Australia. Our laboratories include Innoquest Diagnostics, one of the largest diagnostic service providers in Singapore; Innoquest Pathology (formerly Gribbles Pathology), a market leader in Malaysia; and Safework Health, a leading occupational health provider ...
At Pathology Asia, we understand how critical a medical lab result can be for you. We are one of you, whether you're a patient, a doctor, or a loved one. Our goal is to provide quality and...
Dec 19, 2019 · Determined to improve access to health care and contain its escalating costs, Pathology Asia Group CEO and founder Dr Christopher Ting is bringing a new vision of pathology services to South-East Asia.
Aug 4, 2022 · The Covid-19 pandemic boosted demand for quick diagnostic testing to unprecedented levels, bringing into focus the crucial role of pathology players in the healthcare ecosystem. What trends in healthcare and medicine are driving the regional growth potential of the pathology industry?
Dec 9, 2021 · SINGAPORE: Private equity firm TPG Capital Asia is exploring selling a stake in its pathology business in the region ahead of a potential initial public offering (IPO) for the unit, according to people with knowledge of the matter.
Aug 5, 2022 · We find out from Dr Christopher Ting, CEO of Pathology Asia Group, which runs a network of pathology labs across Southeast Asia, including Innoquest Pathology in Malaysia (formerly known as Gribbles Pathology).
Jan 19, 2022 · Private equity firm TPG Capital Asia is close to an agreement to sell a minority stake in Pathology Asia Holdings Pte in a deal that values the health-care business at about $2 billion, according...
Nabil Fawzi. EXECUTIVE director & chief executive OFFICER. Nabil is currently the Deputy Group CEO of Pathology Asia. He is also the founding CFO, and has been instrumental in the establishment and growth of the group to becoming the largest in Southeast Asia.
